CRISPR and other new technologies open doors for drug development, but which diseases get priority? It comes down to money and science
Prescription drugs and vaccines revolutionized healthcare, dramatically reducing deaths from diseases and improving the quality of life around the world. But how do researchers, universities, hospitals and the pharmaceutical industry decide which diseases to develop drugs for? In my work as director of the Health Outcomes, Policy, and Evidence Synthesis group at the University of … Read more